Aprea Therapeutics, Inc.(APRE)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APRE Aprea Therapeutics, Inc.

未开盘 11-15 16:00:00 EST

3.25

-0.10

-2.99%

盘后3.25

+0.000.00%

16:22 EST

最高3.54	最低3.05	成交量1.55万
今开3.28	昨收3.35	日振幅14.63%
总市值1,765万	流通市值1,293万	总股本543.19万
成交额5.11万	换手率0.39%	流通股本397.73万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APRE","market":"US","secType":"STK","nameCN":"Aprea Therapeutics, Inc.","latestPrice":3.25,"timestamp":1731704400000,"preClose":3.35,"halted":0,"volume":15517,"hourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":3.25,"latestTime":"16:22 EST","volume":6,"amount":20.28,"timestamp":1731705746830},"delay":0,"floatShares":3977267,"shares":5431903,"eps":-2.729579,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.1,"latestTime":"11-15 16:00:00 EST","open":3.28,"high":3.54,"low":3.05,"amount":51079.593002,"amplitude":0.146269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.729579,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1570075200000,"adjPreClose":3.35,"postHourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":3.25,"latestTime":"16:22 EST","volume":6,"amount":20.28,"timestamp":1731705746830},"volumeRatio":0.8384666871668177,"impliedVol":3.9995,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/APRE/tweets","defaultTab":"tweets","newsList":[{"id":"2482738819","title":"Aprea Therapeutics, Inc.盘中异动 快速上涨6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738819?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:30","pubTimestamp":1731335433,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时30分，Aprea Therapeutics, Inc.股票出现波动，股价急速拉升6.20%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为404.64%、124.52%、59.68%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Oragenics Inc.、Nuvectis Pharma, Inc.，振幅分别为22.57%、9.87%、5.46%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223033abb660a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223033abb660a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APRE"],"gpt_icon":0},{"id":"2481102987","title":"Aprea Therapeutics, Inc.股价重挫11.56% 市值跌75.83万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102987?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:01","pubTimestamp":1731078079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时01分，Aprea Therapeutics, Inc.股票出现波动，股价急速跳水11.56%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Fortrea Holdings Inc.、Inhibikase Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为519.51%、45.75%、37.30%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为86.00%、33.33%、31.72%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230119971a5644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230119971a5644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2481604495","title":"Aprea Therapeutics Inc    预计每股亏损 74 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481604495","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481604495?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:51","pubTimestamp":1730901092,"startTime":"0","endTime":"0","summary":"   * Aprea Therapeutics Inc    预计将在11月7日公布截至2024年9月30日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于宾夕法尼亚州多伊尔斯敦的公司的营收预计将从去年同期的31.9万美元降至22.5万美元，降幅为29.5%。* LSEG 分析师对 Aprea Therapeutics Inc 的平均预期是每股亏损 74 美分。* 华尔街对 Aprea Therapeutics Inc 的 12 个月目标价中位数为 16.00 美元，高于其最新收盘价 3.86 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","APRE"],"gpt_icon":0},{"id":"2480838814","title":"Aprea Therapeutics, Inc.盘中异动 大幅拉升5.88%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480838814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480838814?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:56","pubTimestamp":1730472983,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时56分，Aprea Therapeutics, Inc.股票出现波动，股价急速拉升5.88%。截至发稿，该股报4.14美元/股，成交量7557股，换手率0.14%，振幅6.14%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122562398e4009b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122562398e4009b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2479756790","title":"Aprea Therapeutics, Inc.盘中异动 下午盘股价大跌5.65%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479756790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479756790?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:51","pubTimestamp":1730314281,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日02时51分，Aprea Therapeutics, Inc.股票出现波动，股价急速下挫5.65%。截至发稿，该股报4.01美元/股，成交量4412股，换手率0.08%，振幅7.28%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103102512198e3f7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103102512198e3f7b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APRE","BK4139"],"gpt_icon":0},{"id":"2479289689","title":"Aprea Therapeutics, Inc.盘中异动 股价大跌5.84%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479289689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479289689?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:16","pubTimestamp":1730211407,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时16分，Aprea Therapeutics, Inc.股票出现波动，股价大幅下跌5.84%。截至发稿，该股报4.03美元/股，成交量585股，换手率0.01%，振幅0.00%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029221647971a2f46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029221647971a2f46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APRE","BK4139"],"gpt_icon":0},{"id":"2477813360","title":"Aprea Therapeutics, Inc.盘中异动 临近收盘大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477813360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477813360?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:52","pubTimestamp":1729626767,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时52分，Aprea Therapeutics, Inc.股票出现异动，股价快速下跌5.81%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为6993.38%、5267.00%、2228.25%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303524798e3dd4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303524798e3dd4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2476696120","title":"Aprea Therapeutics, Inc.盘中异动 急速上涨6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476696120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476696120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171905,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Aprea Therapeutics, Inc.股票出现异动，股价快速拉升6.29%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Molecular Templates, Inc.、Tevogen Bio Holdings Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为300.71%、190.64%、140.80%，振幅较大的相关个股有Tevogen Bio Holdings Inc.、Molecular Templates, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为25.00%、21.53%、12.58%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131459f4a861b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131459f4a861b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2474094330","title":"Aprea Therapeutics, Inc.盘中异动 早盘急速拉升5.12%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474094330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474094330?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:32","pubTimestamp":1728653531,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时32分，Aprea Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为90.56%、38.19%、11.54%，振幅较大的相关个股有Heron Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Immix Biopharma, Inc.，振幅分别为21.40%、16.70%、7.46%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121321195a07496&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121321195a07496&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APRE","BK4139"],"gpt_icon":0},{"id":"2474372278","title":"Aprea Therapeutics, Inc.盘中异动 早盘快速下跌9.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474372278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474372278?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:26","pubTimestamp":1728487562,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时26分，Aprea Therapeutics, Inc.股票出现波动，股价大幅下跌9.27%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.、Creative Medical Technology Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为683.86%、406.90%、211.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.，振幅分别为108.00%、45.37%、39.02%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100923260298e3b7ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100923260298e3b7ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2473105315","title":"Aprea Therapeutics, Inc.盘中异动 急速跳水8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105315?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:36","pubTimestamp":1728308212,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时36分，Aprea Therapeutics, Inc.股票出现异动，股价大幅下跌8.46%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Scholar Rock Holding Corporation、Nutriband Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为589.13%、49.01%、11.91%，振幅较大的相关个股有Scholar Rock Holding Corporation、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cue Biopharma, Inc.，振幅分别为31.81%、18.44%、15.52%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致该小组通过合成的致死率专注于精确肿瘤学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213653ab681ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213653ab681ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2460004053","title":"Aprea Therapeutics, Inc.盘中异动 急速下跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004053","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004053?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:32","pubTimestamp":1724160757,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时32分，Aprea Therapeutics, Inc.股票出现波动，股价快速跳水7.66%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为1697.43%、321.80%、183.73%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Gri Bio, Inc.，振幅分别为69.53%、16.13%、12.91%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213237ab5ea2fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213237ab5ea2fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2460241787","title":"Aprea Therapeutics, Inc.2024财年第二财季实现净利润-3.47百万美元，同比减少6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241787","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241787?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824039,"startTime":"0","endTime":"0","summary":"8月17日，Aprea Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-3.47百万美元，同比减少6.44%；其中营业收入为561574.00美元，同比增加124.91%，每股基本收益为-0.58美元。从资产负债表来看，Aprea Therapeutics, Inc.总负债3.09百万美元，其中短期债务0.00美元，资产负债比为9.70，流动比率为9.57。机构评级：截至2024年8月17日，当前有3家机构对Aprea Therapeutics, Inc.目标价做出预测，其中目标均价为15.67美元，其中最低目标价为11.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000630959f2dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000630959f2dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APRE"],"gpt_icon":0},{"id":"2459795188","title":"Aprea Therapeutics, Inc.盘中异动 快速拉升6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459795188","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459795188?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:52","pubTimestamp":1723560765,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时52分，Aprea Therapeutics, Inc.股票出现异动，股价快速拉升6.47%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813225245aefea06b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813225245aefea06b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APRE","BK4139"],"gpt_icon":0},{"id":"2457775740","title":"Aprea Therapeutics Inc    预计每股亏损 63 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775740","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775740?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:35","pubTimestamp":1722969328,"startTime":"0","endTime":"0","summary":"   * Aprea Therapeutics Inc    预计将在8月8日公布截至0001年1月1日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于宾夕法尼亚州多伊利斯敦的公司的营收预计将从一年前的25万美元下降80.0%至5万美元。* LSEG 分析师对 Aprea Therapeutics Inc 的平均预期是每股亏损 63 美分。* 华尔街对 Aprea Therapeutics Inc 的 12 个月目标价中位数为 16.00 美元，高于其上一次收盘价 3.53 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APRE","LENZ"],"gpt_icon":0},{"id":"2457177881","title":"Aprea Therapeutics, Inc.盘中异动 早盘股价大跌6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457177881","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457177881?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864785,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Aprea Therapeutics, Inc.股票出现异动，股价大幅下挫6.91%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为991.06%、36.57%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Neurobo Pharmaceuticals, Inc.，振幅分别为13.04%、12.65%、11.29%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213305941fe31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213305941fe31b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2456162455","title":"Aprea Therapeutics, Inc.盘中异动 急速拉升6.12%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456162455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456162455?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:28","pubTimestamp":1722529715,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时28分，Aprea Therapeutics, Inc.股票出现波动，股价大幅拉升6.12%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为1589.29%、344.11%、210.20%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Virax Biolabs Group Limited、Biomea Fusion, Inc.，振幅分别为57.55%、43.37%、43.27%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802002835aefcbad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802002835aefcbad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2450028910","title":"Aprea Therapeutics, Inc.盘中异动 大幅拉升5.76%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450028910","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450028910?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:48","pubTimestamp":1720532922,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时48分，Aprea Therapeutics, Inc.股票出现波动，股价急速上涨5.76%。截至发稿，该股报4.04美元/股，成交量239股，换手率0.00%，振幅0.00%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709214842941f56f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709214842941f56f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2445750410","title":"Aprea Therapeutics, Inc.盘中异动 早盘股价大涨5.53%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445750410","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445750410?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:37","pubTimestamp":1718977022,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时37分，Aprea Therapeutics, Inc.股票出现波动，股价大幅上涨5.53%。Aprea Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Aprea Therapeutics, Inc.公司简介：Aprea Therapeutics Inc是一家临床生物制药公司，致力于开发和商业化可重新激活突变型p53肿瘤抑制蛋白的癌症治疗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121370295c9a8ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121370295c9a8ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APRE","LENZ"],"gpt_icon":0},{"id":"2444180195","title":"HC Wainwright &amp; Co.：重申Aprea Therapeutics(APRE.US)评级，由买入调整至买入评级, 目标价由20.","url":"https://stock-news.laohu8.com/highlight/detail?id=2444180195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444180195?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:43","pubTimestamp":1718635408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","APRE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aprea.com","stockEarnings":[{"period":"1week","weight":-0.0845},{"period":"1month","weight":-0.0714},{"period":"3month","weight":-0.1447},{"period":"6month","weight":-0.3833},{"period":"1year","weight":-0.1333},{"period":"ytd","weight":-0.3085}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aprea Therapeutics, Inc.于2019年5月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于开发和商业化新型癌症疗法，重新激活突变型p53肿瘤抑制蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.060151},{"month":2,"riseRate":0.4,"avgChangeRate":-0.006523},{"month":3,"riseRate":0.4,"avgChangeRate":-0.083115},{"month":4,"riseRate":0,"avgChangeRate":-0.145108},{"month":5,"riseRate":0,"avgChangeRate":-0.155075},{"month":6,"riseRate":0.4,"avgChangeRate":0.033427},{"month":7,"riseRate":0.2,"avgChangeRate":-0.054462},{"month":8,"riseRate":0.4,"avgChangeRate":0.009617},{"month":9,"riseRate":0.4,"avgChangeRate":-0.051894},{"month":10,"riseRate":0.4,"avgChangeRate":0.026808},{"month":11,"riseRate":0.5,"avgChangeRate":-0.074982},{"month":12,"riseRate":0.4,"avgChangeRate":-0.03668}],"exchange":"NASDAQ","name":"Aprea Therapeutics, Inc.","nameEN":"Aprea Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aprea Therapeutics, Inc.(APRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aprea Therapeutics, Inc.(APRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aprea Therapeutics, Inc.,APRE,Aprea Therapeutics, Inc.股票,Aprea Therapeutics, Inc.股票老虎,Aprea Therapeutics, Inc.股票老虎国际,Aprea Therapeutics, Inc.行情,Aprea Therapeutics, Inc.股票行情,Aprea Therapeutics, Inc.股价,Aprea Therapeutics, Inc.股市,Aprea Therapeutics, Inc.股票价格,Aprea Therapeutics, Inc.股票交易,Aprea Therapeutics, Inc.股票购买,Aprea Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aprea Therapeutics, Inc.(APRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aprea Therapeutics, Inc.(APRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况